Eli Lilly

UnitedHealth Group

Johnson & Johnson

AbbVie

Merck

Abbott Labs

Thermo Fisher Scientific

Intuitive Surgical

Amgen

Danaher

iShares U.S. Healthcare ETF

IYH tracks a cap-weighted index of pharmaceutical, biotechnology, health care services and equipment companies in the US.

iShares U.S. Healthcare Providers ETF

Harbor Health Care ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

UnitedHealth (UNH) reported better-than-expected third-quarter 2023 results. Earnings and revenues breezed past the Zacks Consensus Estimate.

UnitedHealth Beats on Q3 Earnings, Raises View: ETFs to Gain

iShares U.S. Healthcare ETF is not recommended for long-term holding due to diminished long-term earnings growth and rich valuation. IYH has better downside protection than the S&P 500 index and has performed in line with the index in the past. The long-term growth outlook for IYH is weaker than the S&P 500 index, making it less attractive for investors.

IYH: Long-Term Growth Outlook Not As Bright As Before

iShares U.S. Pharmaceuticals ETF

Horizon Kinetics Medical ETF

Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 earnings report and an optimistic outlook. ETFs having the largest exposure to the drug maker could be compelling picks to tap the strong growth.

Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap

First Trust Nasdaq Pharmaceuticals ETF 

Hawaiian Electric Industries

Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.

5 ETFs to Buy on JNJ's Q2 Earnings Strength

Pharmaceuticals/biotechnology is the most attractive subsector regarding both value and quality scores. Healthcare equipment is the most overpriced healthcare industry. Fast facts on iShares U.S. Healthcare ETF. 10 healthcare stocks cheaper than their peers in July.

IYH: Healthcare Dashboard For July

UnitedHealth (UNH) reported better-than-expected second-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues. The company lifted the lower end of its full-year earnings guidance.

UnitedHealth Beats Q2 Earnings, Updates View: ETFs to Gain

IYH bets on stocks of companies engaged in the business of pharmaceutical and managed healthcare - two sectors that have relatively stable price growth. Healthcare expenditure holds up in times of deteriorating credit conditions and also when retail investors' interest in the stock market reaches the floor. Over the long run (5 to 10 years), IYH generated strong price growth because most of the large-cap stocks in which it has invested delivered strong returns.

IYH: Focus On Pharmaceutical And Managed Healthcare Stocks Is Paying-Off

First Trust Industrials/Producer Durables AlphaDEX Fund

SPDR S&P Homebuilders ETF

Consumer Staples Select Sector SPDR Fund

Investors could be well served by ETFs from sectors that house the top-ranked industries.

4 Top-Ranked Sector ETFs to Buy in the Second Half

First Trust Capital Strength ETF

SPDR Portfolio S&P 500 High Dividend ETF

Vanguard High Dividend Yield ETF

The Wall Street rally in the first half of 2023 involved a narrow market breadth. Hence, there were many ETF under-performers.

5 ETF Underdogs of 1H Likely to Turnaround in 2H

DiCE Molecules Holding LLC

VanEck Vectors Pharmaceutical ETF

Eli Lilly (LLY) has agreed to acquire DICE Therapeutics (DICE) in a cash deal worth approximately $2.4 billion. This strategic move is part of Eli Lilly's efforts to bolster its immunology pipeline, specifically targeting immune disease-related treatments.

ETFs to Capitalize on Eli Lilly's Buyout of DICE Therapeutics

iShares U.S. Aerospace & Defense ETF

Fresh off the debt-ceiling showdown, Washington may be looking at another fiscal crisis: a government shutdown.

Government shutdown fears are growing. Here's what to watch, and when to expect trouble.

First Trust NASDAQ Global Auto Index Fund

iShares Global Clean Energy ETF

iShares U.S. Consumer Services ETF

iShares U.S. Real Estate ETF

SPDR S&P Insurance ETF

VanEck Vectors Agribusiness ETF

Vanguard Real Estate ETF

Energy Select Sector SPDR Fund

SPDR S&P Transportation ETF

The annual inflation rate in the United States dropped to 4.9% in April 2023, the lowest since April 2021.

Sector ETFs Likely to Gain on April Inflation Data

IYH: Even During A Recession, Folks Want To Stay Healthy (Rating Upgrade).

IYH: Even During A Recession, Folks Want To Stay Healthy (Rating Upgrade)

ETFs to Buy on Solid Q1 JNJ Earnings Results

UnitedHealth Group reported better-than-expected first-quarter 2023 results, breezing past the Zacks Consensus Estimate for earnings and revenues.

UnitedHealth's Solid Q1 Earnings Put These ETFs in Focus

Virtus LifeSci Biotech Clinical Trials ETF

VanEck Vectors Biotech ETF

First Trust NYSE Arca Biotechnology Index Fund

iShares Nasdaq Biotechnology ETF

iShares U.S. Medical Devices ETF

Invesco Dynamic Biotechnology & Genome ETF

Invesco Dynamic Pharmaceuticals ETF

Invesco S&P 500 Equal Weight Health Care ETF

SPDR S&P Biotech ETF

SPDR S&P Pharmaceuticals ETF

How SVB's collapse is impacting healthcare startups. Pfizer to buy Seagen for $43B.

The Fall Of SVB: What It Means For Healthcare Startups

Healthcare is a defensive sector that enjoys major secular tailwinds. It is a veritable freight train when you look at the aging demographic trends that are estimated worldwide. IYH exhibits low volatility, a low beta, and is extremely resilient in recessionary periods. It sports a 10-year annualized return of 13.56%.

IYH: Destiny's Favorite Child

These exchange-traded funds have soundly beaten the S&P 500 over the past 10 years.

Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul

The world's biggest healthcare products' maker continued with its long streak of earnings beat and missed revenue estimates.

ETFs in Focus on JNJ's Mixed Q4 Earnings Results

UnitedHealth Group (UNH) breezed past the Zacks Consensus Estimate for earnings.

UnitedHealth Beats Q4 Earnings: ETFs in Focus

Global X Longevity Thematic ETF 

ARK Genomic Revolution Multi-Sector ETF

Virtus LifeSci Biotech Products ETF

BlackRock Future Health ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Global X Telemedicine & Digital Health ETF

Fidelity MSCI Health Care ETF

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares Global Healthcare ETF

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Novo Nordisk

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Simplify Health Care ETF

Invesco S&P SmallCap Health Care ETF

Invesco DWA Healthcare Momentum ETF

ALPS Medical Breakthroughs ETF

Wisdomtree BioRevolution Fund

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk.

Worried About 2023? Here's a Safer Way to Invest in Stocks This Year

As most of you know, a high inflation and rising interest rate environment favors defensive sectors that typically outperform in recessionary periods. Healthcare is one such sector. This year, the iShares U.S. Healthcare ETF has outperformed the S&P 500 by 14%.

IYH: Healthcare Stocks Will Likely Outperform In The New Year

iShares Core Growth Allocation ETF

SPDR Dow Jones Industrial Average ETF

Invesco QQQ

SPDR S&P 500 ETF Trust

AOR and IYH saw massive trading volumes in yesterday session.

Multi-Asset and Healthcare: 2 ETFs to Watch for Outsized Volume

Blackrock Inc

iShares U.S. Utilities ETF

iShares Core S&P 500 ETF

ProShares S&P 500 Dividend Aristocrats ETF

Vanguard Dividend Appreciation ETF

One of the main risks to your portfolio is sequence of returns risk - the need to sell stocks to generate income. Obviously, the greater the income, the less need to sell stocks.

Dividend Growth And Your Retirement Portfolio

News for iShares U.S. Healthcare ETF ETF (IYH)